BioSig Technologies, Inc. (Nasdaq: BSGM) has officially completed its merger with blockchain-focused Streamex Exchange Corporation, marking a dramatic pivot for the company. Once known for its innovations in medical technology, BioSig now sets its sights on the fast-growing market for real-world asset (RWA) tokenization.
The merger was finalized on May 28, 2025, following a definitive share exchange agreement signed on May 23. Streamex is now a wholly-owned subsidiary of BioSig, with the combined entity focused on creating blockchain-based solutions for the global commodities markets. As part of the agreement, Streamex shareholders could own up to 75% of BioSig’s fully diluted outstanding shares, contingent on regulatory and shareholder approval.
This transition brings new leadership to the forefront. Streamex co-founder Henry McPhie has taken the reins as CEO and joined the board of directors, while fellow co-founder Morgan Lekstrom now serves as Chairman. Former BioSig CEO Anthony Amato remains on the board to support the integration of the two companies.
$1.1B in Growth Financing to Target Gold and Commodity Tokenization
Just weeks after the merger, BioSig announced definitive agreements for up to $1.1 billion in growth capital. The financing package includes $100 million in senior secured convertible debentures and a $1 billion equity line of credit over the next 36 months. These funds are expected to fuel the company’s efforts to tokenize physical commodities, beginning with gold.
The new strategy involves launching a gold-backed treasury management product aimed at institutions seeking blockchain-based alternatives to traditional commodity exposure. Streamex’s underlying infrastructure, built on the Solana blockchain, will serve as the backbone for this initiative, offering transparency, speed, and reduced costs.
The company has brought on high-profile advisors to guide the transition and growth strategy. These include Frank Giustra, founder of Wheaton Precious Metals and GoldCorp, who will advise on commodities, as well as capital markets veterans like Mathew August and Mitch Williams.
Positioning for a Trillion-Dollar Market
With its new blockchain-based focus, BioSig is positioning itself to compete in a global commodities market estimated to be worth $142 trillion. Gold alone accounts for approximately $233 billion in daily trading volume—dwarfing Bitcoin and other digital assets. The broader RWA tokenization market is forecast to grow to $16 trillion by 2030, offering a massive opportunity for early movers.
By offering programmable, liquid, and transparent representations of real-world commodities, BioSig hopes to become a dominant player in this emerging space. The company’s gold-backed treasury initiative is designed not just as a product, but as a proof-of-concept for the institutional adoption of tokenized commodities.
The BioSig-Streamex merger marks one of the most notable examples of a publicly listed U.S. company executing a full pivot into blockchain technology. With a seasoned leadership team, strong advisory board, and significant capital backing, the combined entity is poised to reshape how institutional investors access and trade physical assets in the digital age.
